Epidemiology of Leprosy in French Guiana

NCT ID: NCT05031091

Last Updated: 2021-09-01

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 368 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2020-01-07
• Study Completion Date: 2023-12-31

Brief Summary

The main objective of the present study is the genotyping of M. leprae strains found in leprosy patients in French Guiana. The secondary objectives are to investigate the presence of M. lepromatosis in these patients, the molecular research of M. leprae resistance to anti-leprosy antibiotics, the study of risk factors for leprosy in humans in Guyana and in particular direct or indirect contact with armadillos, as well as the determination of phylogenetic links between the M. leprae strains found in French Guiana, and with the regional and world reference strains Epidemiology of leprosy in French Guiana.

Detailed Description

Rationale: Leprosy (also known as Hansen's disease) is a chronic infection caused by intracellular mycobacteria, Mycobacterium leprae and Mycobacterium lepromatosis (discovered in 2008), preferentially affecting the skin and peripheral nervous system. The disease in humans is potentially disabling and stigmatising.

The modes of transmission of leprosy are not yet fully understood, although it is generally accepted that the main mode of transmission is human-to-human. Apart from humans, the only other major confirmed animal reservoir of M. leprae is the 9-banded armadillo Dasypus novemcinctus, which is found only in the Americas. Recent studies in the southern United States suggest transmission of M. leprae between D. novemcinctus and humans, where 64% of human cases may be attributable to armadillos. Uncertainties remain regarding the zoonotic nature of the disease outside the US and the precise mode of transmission.

The disease is endemic on the American continent where 92% of new cases come from Brazil. In French Guiana - bordering Brazil - leprosy is still present and shows a tendency to recrudesce with about 10 new cases per year. Armadillo consumption is frequent.

Objectives: The main objective of the present study is the genotyping of M. leprae strains found in leprosy patients in French Guiana. The secondary objectives are to investigate the presence of M. lepromatosis in these patients, the molecular research of M. leprae resistance to anti-leprosy antibiotics, the study of risk factors for leprosy in humans in Guyana and in particular direct or indirect contact with armadillos, as well as the determination of phylogenetic links between the M. leprae strains found in French Guiana, and with the regional and world reference strains Population and methods: A cross-sectional study will be conducted on approximately 150 cases of leprosy diagnosed between 2006 and 2022 in French Guyana, seen by the department's anti-leprosy service and for which a skin biopsy (or dermal smear or nasal swab) is available. Genotyping of M. leprae and the search for antibiotic resistance, as well as the search for M. lepromatosis will be carried out by molecular biology. Human strains will be compared with environmental strains from French Guiana and with reference strains found in humans and armadillos. A minimum-spanning-tree and maximum parsimony analysis will be performed to determine the phylogenetic relationships between the different strains.

A 3:1 matched case-control study will be conducted to assess risk factors for leprosy in French Guiana. The 92 cases will be recruited from among leprosy cases diagnosed between 2006 and 2022 in French Guyana, seen by the departmental leprosy control. The 276 controls will be recruited by dermatologists from the Cayenne hospital, throughout the territory, by matching 3 controls per case according to sex and age (± 5 years). A standardised exposure questionnaire will be conducted face to face or by telephone. The search for leprosy risk factors and in particular direct or indirect contact with armadillos (proximity / hunting / handling / consumption) will be explored by univariate and then multivariate conditional logistic regressions taking into account known potential confounding factors.

Conditions

Hansen's Disease

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: OTHER

Study Groups

Case: patients with confirmed leprosy

diagnosed or followed up in French Guiana between the beginning of 2006 and the end of 2022

standardised exposure questionnaire

Intervention Type: OTHER

A standardised exposure questionnaire will be conducted face to face or by telephone. The search for risk factors for leprosy and in particular direct or indirect contact with armadillos will be explored

Control: patient with a dermatological condition not clinically suspicious of leprosy

Any patient, of any age, consulting for a dermatological pathology not clinically suspicious of leprosy during a dermatological consultation by a practitioner of the Cayenne Hospital

standardised exposure questionnaire

Intervention Type: OTHER

A standardised exposure questionnaire will be conducted face to face or by telephone. The search for risk factors for leprosy and in particular direct or indirect contact with armadillos will be explored

Interventions

standardised exposure questionnaire

A standardised exposure questionnaire will be conducted face to face or by telephone. The search for risk factors for leprosy and in particular direct or indirect contact with armadillos will be explored

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

FOR TRANSVERSAL STUDY:

• any patient, regardless of age, consulting a practitioner at the Cayenne Hospital with a clinical suspicion of leprosy
• Diagnosis of leprosy, confirmed histologically or bacteriologically, made in Guyana between 2006 and 2022
• Skin biopsy (or dermal smear or nasal swab) available in the anatomopathology department of the Andrée Rosemon Hospital and analysable (correct state of preservation and sufficient quantity of tissue)

FOR CASE-CONTROL STUDY - CASES:

• any patient, regardless of age, consulting a practitioner at the Cayenne Hospital with a clinical suspicion of leprosy
• Diagnosis of leprosy, confirmed histologically or bacteriologically, made in Guyana between 2006 and 2022

FOR CASE-CONTROL STUDY - CONTROL:

Any patient, of any age, consulting for a dermatological pathology not clinically suspicious of leprosy during a dermatological consultation by a practitioner of the Cayenne Hospital

Exclusion Criteria

FOR TRANSVERSAL STUDY:

• Opposition to participation
• Diagnosis of leprosy invalidated after inclusion

FOR CASE-CONTROL STUDY - CASES:

• Opposition to participation
• Inability to answer to the questionnaire
• Diagnosis of leprosy invalidated after inclusion

FOR CASE-CONTROL STUDY - CONTROL:

• Opposition to participation
• Inability to answer to the questionnaire

• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Centre Hospitalier de Cayenne

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

General Hospital of Cayenne

Cayenne, , French Guiana

Site Status: RECRUITING

Countries

French Guiana

Facility Contacts

Mathieu Nacher, Pr

Role: primary

mathieu.nacher@ch-cayenne.fr

0594395385

Roxane Schaubb, PhD

Role: backup

roxane.schaub@ch-cayenne.fr

05 94 39 53 88

Other Identifiers

EPI-LEPR

Identifier Type: -

Identifier Source: org_study_id